Antibacterial Drugs Market Size, Share, Growth, Trends, Consumption, Production, Revenue and Forecast 2021 - 2027

Table of Content

Chapter 1. Preface

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

    1.3. Assumptions and Acronyms Used

Chapter 2. Research Methodology 

Chapter 3.  Executive Summary 

Chapter 4. Market Overview

    4.1. Product Overview

    4.2. Key Industry Developments 

    4.3. Market Dynamics 

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

        4.3.4. Porter’s Five Forces Representation

        4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario

        4.3.6. Antibacterial Drugs Market Outlook

        4.3.7. Anti-Bacterial Drugs Pipeline Analysis 

Chapter 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2017 – 2027

    5.1. Key Findings

    5.2.  Definition

    5.3. Introduction

    5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    5.5. Global Antibacterial Drugs Market Analysis, by Drug Class

        5.5.1. β-lactam 

        5.5.2. Quinolones

        5.5.3. Macrolides

        5.5.4. Tetracycline

        5.5.5. Aminoglycoside

        5.5.6. Sulfonamide

        5.5.7. Phenicols

        5.5.8. Others

    5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    5.7. Global Antibacterial Drugs Market Forecast, by Drug Class

    5.8. Key Trends

Chapter 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration 

    6.1. Key Findings

    6.2. Definitions

    6.3. Introduction

    6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration

        6.5.1. Enteral

        6.5.2. Parenteral

        6.5.3. Others 

    6.6.  Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration

    6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration

Chapter 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 

    7.1.  Key Findings

    7.2. Definitions

    7.3. Introduction 

    7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution

        7.5.1. Hospital Pharmacies

        7.5.2. Drug Stores & Retail Pharmacies

        7.5.3. Online Sales

    7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution

    7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution

    7.8. Key Trends

Chapter 8. Global Antibacterial Drugs Market Analysis, by Region

    8.1.  Key Findings 

    8.2. Introduction

    8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2017 and 2027

    8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region

    8.5. Global Antibacterial Drugs Market Forecast, by Region, 2017–2027

Chapter 9. North America Antibacterial Drugs Market Analysis

    9.1. North America Antibacterial Drugs Market Overview

    9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2017–2027

    9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2017–2027

    9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration

    9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2017–2027

    9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    9.10.  North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution

    9.11.  North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2017–2027

    9.12.  Key Trends

Chapter 10. Europe Antibacterial Drugs Market Analysis

    10.1.  Europe Antibacterial Drugs Market Overview

    10.2.  Europe Antibacterial Drugs Market Forecast, Country wise, 2017–2027

    10.3.  Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    10.4.  Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    10.5.  Europe Antibacterial Drugs Market Forecast, by Drug Class, 2017–2027

    10.6.  Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    10.7.  Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 

    10.8.  Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2017–2027

    10.9.  Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    10.10.  Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution 

    10.11.  Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2017–2027

    10.12.  Key Trends

Chapter 11.  Asia Pacific  Antibacterial Drugs Market Analysis

    11.1.  Asia Pacific  Antibacterial Drugs Market Overview

    11.2.  Asia Pacific  Antibacterial Drugs Market Forecast, Country wise, 2017–2027

    11.3.  Asia Pacific  Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    11.4.  Asia Pacific  Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    11.5.  Asia Pacific  Antibacterial Drugs Market Forecast, by Drug Class, 2017–2027

    11.6.  Asia Pacific  Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    11.7.  Asia Pacific  Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration

    11.8.  Asia Pacific  Antibacterial Drugs Market Forecast, by Routes of Administration, 2017–2027

    11.9.  Asia Pacific  Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    1.1.  Pacific  Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution 

    11.10. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2017–2027

    11.11. Key Trends

Chapter 12.  Latin America  Antibacterial Drugs Market Analysis

    12.1.  Latin America  Antibacterial Drugs Market Overview

    12.2.  Latin America  Antibacterial Drugs Market Forecast, Country wise, 2017–2027

    12.3.  Latin America  Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    12.4.  Latin America  Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    12.5.  Latin America  Antibacterial Drugs Market Forecast, by Drug Class, 2017–2027

    12.6.  Latin America  Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    12.7.  Latin America  Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration

    12.8.  Latin America  Antibacterial Drugs Market Forecast, by Routes of Administration, 2017–2027

    12.9.  Latin America  Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    12.10.  Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution

    12.11.  Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2017–2027

    12.12.  Key Trends

Chapter 13.  Middle East & Africa Antibacterial Drugs Market Analysis

    13.1.  Middle East & Africa   Antibacterial Drugs Market Overview

    13.2.  Middle East & Africa   Antibacterial Drugs Market Forecast, Country wise, 2017–2027

    13.3.  Middle East & Africa  Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2027

    13.4.  Middle East & Africa  Antibacterial Drugs Market Attractiveness Analysis, by Drug Class

    13.5.  Middle East & Africa  Antibacterial Drugs Market Forecast, by Drug Class, 2017–2027

    13.6.  Middle East & Africa  Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2027

    13.7.  Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration

    13.8.  Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2017–2027

    13.9.  Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2027

    13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution

    13.11.  Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2017–2027

    13.12.  Key Trends

Chapter 14.  Competition Landscape

    14.1.  Leading Antibacterial Drugs Sales Analysis 

    14.2.  Competition Matrix

    14.3.  Company Profiles 

        14.3.1. Bayer AG

            14.3.1.1. Company Description

            14.3.1.2. Business Overview

            14.3.1.3. SWOT Analysis

            14.3.1.4. Strategic Overview

        14.3.2. Pfizer Inc.

            14.3.2.1. Company Description

            14.3.2.2. Business Overview

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. Sanofi

            14.3.3.1. Company Description

            14.3.3.2. Business Overview

            14.3.3.3. SWOT Analysis

            14.3.3.4. Strategic Overview

        14.3.4. GlaxoSmithKline plc

            14.3.4.1. Company Description

            14.3.4.2. Business Overview

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Merck & Co., Inc.

            14.3.5.1. Company Description

            14.3.5.2. Business Overview

            14.3.5.3. SWOT Analysis

            14.3.5.4. Strategic Overview

        14.3.6. AstraZeneca

            14.3.6.1. Company Description

            14.3.6.2. Business Overview

            14.3.6.3. SWOT Analysis

            14.3.6.4. Strategic Overview

        14.3.7. Johnson and Johnson Services, Inc.

            14.3.7.1. Company Description

            14.3.7.2. Business Overview

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. Bristol-Myers Squibb Company

            14.3.8.1. Company Description

            14.3.8.2. Business Overview

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

        14.3.9. Novartis AG

            14.3.9.1. Company Description

            14.3.9.2. Business Overview

            14.3.9.3. SWOT Analysis

            14.3.9.4. Strategic Overview

        14.3.10. Allergen 

            14.3.10.1. Company Description

            14.3.10.2. Business Overview

            14.3.10.3. SWOT Analysis

            14.3.10.4. Strategic Overview